PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
25-Apr-2025 ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 ACCESS Newswire
25-Apr-2025 Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM) ACCESS Newswire
25-Apr-2025 Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technological Milestones, and International Capital Market Presence Xlife Sciences AG
25-Apr-2025 iZafe Group Q1 Interim Report, January-March 2025 ACCESS Newswire
24-Apr-2025 Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science ACCESS Newswire
24-Apr-2025 Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds ACCESS Newswire
24-Apr-2025 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical SA
24-Apr-2025 Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025 Heidelberg Pharma AG
24-Apr-2025 OXB Named Among UK’s Best Employers by Financial Times in 2025 OXB
24-Apr-2025 Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients Bioxodes
24-Apr-2025 Mosaic Therapeutics in-licences two clinical-stage assets from Astex Pharmaceuticals Syncona Limited
24-Apr-2025 HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025 HUTCHMED
24-Apr-2025 Hikma reiterates full year guidance following good start to the year Hikma
24-Apr-2025 NEW IQVIA INSTITUTE REPORT WARNS OF ACCESS DISPARITIES FOR CAR T-CELL THERAPY ACROSS EUROPE IQVIA
24-Apr-2025 The UK’s HIV Response is Failing Women – A New Movement Calls for Change akt health a JPA Health company
24-Apr-2025 Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS Pharming
24-Apr-2025 Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers Boehringer Ingelheim
24-Apr-2025 Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development Thermo Fisher Scientific
24-Apr-2025 Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Regeneron Investor Relations
24-Apr-2025 Debiopharm and Oncodesign Services Launch Strategic Collaboration to Propel Radiopharmaceuticals in Preclinical Research Debiopharm